1 |
R.S. Hinz, C.D. Hodsoa, C.R. Lorence and R.H. Guy, In vitropercutaneous penetration: evaluation of the utility of hairless mouse skin, J. Invest. Dermatol., 93, 87-91 (1989)
DOI
ScienceOn
|
2 |
Y.D. Lee, Q.Z. Quan, S.Y. Jung, J.D. Rhee and C.S. Yong, The effect of fatty acids, fatty alcohols and propylene glycol on the penetration of clenbuterol through hairless mouse skin, J. Kor.Pharm. Sci., 29, 329-335 (1999)
|
3 |
M.H.A. Botterblom, M.G.P. Feenstra and E.B.H.W. Erdtsieck-Emste, Detennmation of propranolol, labetalol and clenbuterolin rat brain by high-performance liquid chromatography, J.Chromatogrphy., 613, 121-126 (1993)
DOI
ScienceOn
|
4 |
T.K. Ghosh, W.R. Pfister and S.I. Yum, Transdermal and Topical Drug Dehvery Systems, Inteipharm Press, BuffaloGrove, IL, U.S.A. (1997)
|
5 |
A.C. Williams and B.W. Bany, Essential oils as novel human skin penetration enhancers, Int. J. Pharm., 57, R7-R9 (1989)
DOI
ScienceOn
|
6 |
J.M. Hadgraft, Transdermal drug delivery, Marcel Dekker,New York, U.S.A. (1989)
|
7 |
C.T. O.Neil and P.B. Deasy, Development and evaluatio nusing hairless mouse skin of a traasdermal product, Int. J.Pharm., 48, 247-254 (1988)
DOI
ScienceOn
|
8 |
Y.W. Chien, Novel Drug Delivery System, Marcel Dekker,New York, U.S.A. (1992)
|
9 |
A.C. Williams and B.W. Barry, Transdermal oestradiol permeation: the effects of terpene penetration enhancers, In: Prediction of Percutaneous Penetration: Methods, Measurements, Modelling, R.C. Scott, R.H. Guy, J. Hadgraft and H.E. Bodde(Eds), IBC Technical Services, London, PP. 386-393 (1991)
|
10 |
A.C. Williams and B.W. Barry, Terpenes and the lipid-protein partitioning theory of skin penetration enhancement, Pharm.Res., 8, 17-24 (1991)
DOI
ScienceOn
|
11 |
H. Okabe, Y. Obata, K. Takayama, and T. Nagai, Percutaneous absorption enhancing effect and skin irritation of monocyclic monoterpenes. Drug Des. Detliv., 6, 229-238 (1990)
|
12 |
Y. Obata, K. Takayama, Y. Maitani, Y. Machida and T. Nagai, Effect of pretreatment of skin with cyclic monoterpenes on permeation of diclofenac in hairless rat, Biol, Pharm. Bull., 16, 312-314 (1993)
DOI
ScienceOn
|
13 |
J. Yukawa, K. Sugibayashi and Y. Morimoto, Effect of variousadditives on the skin permeation of ketoprofen from the film forming transdermal formulation, Yakuzaigaku, 49, 254-262 (1989)
|
14 |
D.J. Chatterjee, W.Y. Li and R.T. Koda, Effect of vehicles andpenetration enhancers on the in vitro and in vivo percutaneous absorption of methotrexate and edatrexate through hairlessmouse skin, Pharm. Res., 14, 1058-1065 (1997)
DOI
ScienceOn
|
15 |
B.J. Aungst, N.J. Rogers and E. Shefter, Enhancement of naloxone penetration through human skin in vitro using fattyacids, fatty alcohols, surfactant, sulfoxides and amides, Int. J.Pharm., 33, 225-234 (1986)
DOI
ScienceOn
|
16 |
D. Monti, P. Chetoni, S. Burgalassi, M. Najarro, M. Fabrizio Saettone and E. Boldini, Effect of different terpene-containing essential oils on permeation of estradiol through hairlessmouse skin, Int. J. Pharm., 237, 209-214 (2002)
DOI
ScienceOn
|
17 |
D.D. Kim and Y.W. Chien, Transdermal delivery of dideoxy-neucleoside-type anti-HIV drugs. 2. The effect of vehicle and enhancers on skin permeation, J. Pharm. Sci., 85, 214-219(1996)
DOI
|
18 |
H.S. Gwak and I.K. Chun, Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin, Int. J. Pharm., 236, 57-64 (2002)
DOI
ScienceOn
|
19 |
M. Yamada and Y. Uda, Enhancement of percutaneous absorption of molsidomine, Chem. Pharm. Bull, 35, 3390-3398 (1987)
DOI
ScienceOn
|
20 |
A.K-. Jain, N.S. Thomas and R. Panchagnula, Transdermal drug delivery of imipramine hydrochloride.: I. Effect of terpenes, J. Control. Rel., 79, 93-101 (2002)
DOI
ScienceOn
|
21 |
B. M. Magnusson, P. Runn, K. Karlsson and L. -O. D.Koskinen, Terpenes and ethanol enhance the transdermal permeation of the tripeptide thyrotropin releasing hormone in human epidermis, Int. J. Pharm., 157, 113-121 (1997)
DOI
ScienceOn
|
22 |
B.W. Barry, Lipid-Protein-Partitioning theory of skin penetration enhancement, J. Control. ReL, 15, 237-248 (1987)
|
23 |
H. Sasaki, M. Kojima, J. Nakamura and J. Shibasaki, Enhancing effect of pyrrolidone derivatives on the transdermal penetration of 5-fluorouracil, triamcinolone acetonide, indomethacin, and flurbiprofen, J. Pharm, Sci., 80, 533-538 (1991)
DOI
|
24 |
P.A. Cornwell and B.W. Barry, Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil, J. Pharm. Pharmacol, 46, 261-269 (1994)
DOI
ScienceOn
|
25 |
J. Shokri, A. Nokhodchi, A. Dashbolaghi, D. Hassan-Zadeh, T.Ghafourian and M. Barzegar Jalali, The effect of surfactantson the skin penetration of diazepam, Int. J. Pharm., 228, 99-107 (2001)
DOI
ScienceOn
|
26 |
P. Ashton, K.A. Walters, K.R. Brain and J. Hadgraft, Surfactanteffects in percutaneous absoption. I. Effects on the transdrmalflux of methyl nicotmate, Int J. Pharm., 87, 261-264 (1992)
DOI
ScienceOn
|
27 |
H. Okuyama, Y. Ikeda, S. Kasai, K. Imamori, K. Takayama and T. Nagai, Influence of non-ionic surfactants, pH and propylene glycol on percutaneous absorption of piroxicam from cataplasm, Int. J. Pharm., 186, 141-148 (1999)
DOI
ScienceOn
|
28 |
Von Z, Kopitar and A. Zimmer, Vergleich des pharmaco-kinetischen Profils von Clenbuterol bei Ratte und Hund w hrend toxikologischer Untersuchungen, Arzneim-Forsch, 26, 1450-1455 (1976)
|
29 |
S. Santoyo and P. Ygartua, Effect of skin pretreatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical application, European J. Pharm.Biopharm., 50, 245-250 (2000)
DOI
ScienceOn
|
30 |
C. Pasotti, A. Capra and C. Vibelli, NAB 365 (clenbuterol) and salbutamol in asthmatics: a double-blind clinical trial, Int. J. Ctin. Pharmcol. Biopharm., 17, 176-180 (1979)
|
31 |
Y. Itaru, I. Kohji. and N. Mitsuyoshi, Pharmacokinetics of plasma and urine clenbuterol in man, rat, and rabbit, J.Pharmacobio-Dyn., 8, 385-391 (1985)
DOI
|
32 |
F. Masaki, K. Yumie, H. Takuma and M. Tamotsu, Coughreceptor sensitivity and bronchial responsiveness in patientswith only chronic nonproductive cough: In view of effect of bronchodilator therapy, J. Asthma, 31, 463-472 (1994)
DOI
ScienceOn
|
33 |
R.J. Scheuplein, Skin as a barrier : In The Physiology and Pathophysiology of Skin. Vol. 5, A. Jarret (Ed.), Academic Press, New York, U.S.A., PP. 1693-1730 (1978)
|
34 |
E.R. Cooper, E.W. Merrit and R.L. Smith, Effect of fattyacids and alcohols on the penetration of acyclovir across human skin in vitro, J. Pharm. Sci., 74, 688-689 (1985)
DOI
|